Saturday, November 14, 2026

USD/CNH Bearish By 1% In The Last 5 Sessions

Automated market report from our archive (2020–2024), published before source-traceability. How we work

USD/CNH Bearish By 1% In The Last 5 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.14% for the last 5 sessions. At 15:11 EST on Sunday, 30 July, USD/CNH (USDCNH) is $7.15.

USD/CNH's yearly highs and lows, it's 0% down from its 52-week low and 0% down from its 52-week high.

News about

  • According to FXStreet on Friday, 28 July, "At the time of writing, EUR/USD is trading almost unchanged on the day at 1.0970."
  • According to FXStreet on Friday, 28 July, "Following the dovish Fed and strong US economic data, the US Dollar clings to recovery gains, keeping EUR/USD in weekly lows on the 1.0900 level.. ", "FXStreet Analyst Dhwani Mehta offers a brief technical outlook for EUR/USD and explains: "Having breached the critical 21-day Simple Moving Average (SMA) on a daily closing basis on Thursday, Euro sellers are extending control heading toward the US PCE Inflation data release. "
  • According to FXStreet on Friday, 28 July, "The Euro (EUR) continues to face significant pressure and loses ground against the US Dollar (USD) as the week comes to a close, resulting in EUR/USD weakening to levels not seen in three weeks, near 1.0940.", "The constructive view of EUR/USD appears unchanged as long as the pair trades above the key 200-day SMA."
  • Eur/usd bounces off 1.0950 support as German, US inflation cues loom. According to FXStreet on Friday, 28 July, "That said, the recently positive mood in the market, amid hopes of a sooner end to the restrictive monetary policies at major central banks, seems to weigh on the US Dollar and allow the EUR/USD to print a corrective bounce.", "Moving on, the first prints of the German GDP and inflation clues will precede the Fed's favorite inflation gauge, namely the Core Personal Consumption Expenditure (PCE) Price Index for June, to entertain the EUR/USD moves. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com